MICHAEL D'AGOSTA: Open Payments
NPI 1962963785 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 26 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $107 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $159 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Janssen Pharmaceuticals, Inc | 3 | $82 |
| Neurocrine BioSciences, Inc. | 3 | $78 |
| ABBVIE INC. | 3 | $61 |
| Alkermes, Inc. | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: COBENFY, INVEGA SUSTENNA, INGREZZA, ABILIFY ASIMTUFII, VRAYLAR, ARISTADA, ABILIFY MAINTENA, LYBALVI.
Industry payments across FL — which companies pay providers there.
